Table 1.

A division of the number of subjects with the percentage share in the group, taking into account: tumor location, tumor shape and color, type of treatment applied, and the dose

		Study group, N = 344
		n	%
Eye
1	Right	152	44.19
2	Left	192	55.81
Location
1	Top	50	14.53
2	Temporal area – top	52	15.12
3	Nasal area – top	26	7.56
4	Temple	80	23.26
5	Nose	20	5.81
6	Bottom	52	15.12
7	Temporal area – bottom	33	9.59
8	Nasal area – bottom	30	8.72
No data		1	0.29
The location of the anterior margin of the tumor
1	Disc	0	0.00
2	< 1 dd from the disc	0	0.00
3	1-2 dd from the disc	0	0.00
4	< 1 dd from the macula	0	0.00
5	1-2 dd from the macula	0	0.00
6	Macula	0	0.00
7	From equator to the back	142	41.28
8	Equator to the limbus	79	22.97
9	Ciliary body	117	34.01
10	Iris	5	1.45
No data		1	0.29
The location of the posterior margin of the tumor
1	Disc	25	7.27
2	< 1 dd from the disc	26	7.56
3	1-2 dd from the disc	51	14.83
4	< 1 dd from the macula	28	8.14
5	1-2 dd from the macula	62	18.02
6	Macula	68	19.77
7	From equator to the back	75	21.80
8	Equator to the limbus	8	2.33
9	Ciliary body	0	0.00
No data		1	0.29
Shape
1	Dome-shaped	215	62.50
2	Mushroom-shaped	129	37.50
3	Flat	0	0.00
Colour
1	Brown	92	26.74
2	Medium-colored	174	50.58
3	Amelanotic	78	22.67
TNM
T1		3	0.90
T2		78	25.10
T3		235	68.50
T4		19	5.50
Treatment
1	I-125 brachytherapy	334	97.09
2	I-125 brachytherapy + transpupillary thermotherapy	10	2.91
Dose for the tumor top
From 80 Gy to 100 Gy		177	51.45
Above 100 Gy to 120 Gy		167	48.55